Literature DB >> 15647177

Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux.

M Cicala1, A Gabbrielli, S Emerenziani, M P L Guarino, M Ribolsi, R Caviglia, G Costamagna.   

Abstract

BACKGROUND AND AIMS: Improvements in symptoms following endoscopic procedures for gastro-oesophageal reflux disease (GORD) are seldom supported by normalisation of acid exposure time at the distal oesophagus. However, the distribution of gastric acid within the proximal oesophagus is a main determinant of symptom generation in GORD patients. In this study, our aim was to assess the effect of endoscopic insertion of hydrogel expandable prostheses into the oesophageal submucosa on spatiotemporal characteristics of gastro-oesophageal reflux.
METHODS: Oesophageal manometry and multichannel ambulatory 24 hour pH monitoring were carried out in nine patients before and six months after the endoscopic procedure. Dynamic characteristics of gastro-oesophageal reflux in patients were also compared with those in 13 asymptomatic controls.
RESULTS: Acid exposure time (AET) at the distal oesophagus decreased from 11.7% (95% confidence interval 6.1-21.8) at baseline to 7.7% (3.7-11.6) at follow up (NS). Of the nine patients, distal AET normalised in three. AET at the middle (7.6% (2.9-12.3)) and proximal (2.4% (0.1-4.8)) oesophagus decreased significantly in all patients (2.4% (0.3-4.5), p <0.01; 1.2% (0.2-2.2), p<0.05 respectively). Proximal extent of acid events significantly decreased in all patients at follow up (37.3% v 9.5%), reaching values observed in asymptomatic controls. Median GORD health related quality of life scores significantly improved from 35.5 at baseline to 9.4.
CONCLUSIONS: Despite the lack of a significant improvement in traditional pH variables, endoscopic implant of hydrogel prostheses above the lower oesophageal sphincter significantly decreases proximal spread of acid reflux into oesophageal body. This effect would explain the improvement in symptoms in patients six months after therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647177      PMCID: PMC1774830          DOI: 10.1136/gut.2004.040501

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

Authors:  M F Vela; L Camacho-Lobato; R Srinivasan; R Tutuian; P O Katz; D O Castell
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial.

Authors:  C J Filipi; G A Lehman; R I Rothstein; I Raijman; G V Stiegmann; J P Waring; J G Hunter; C J Gostout; S A Edmundowicz; D P Dunne; P A Watson; D A Cornet
Journal:  Gastrointest Endosc       Date:  2001-04       Impact factor: 9.427

3.  Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD.

Authors:  G Triadafilopoulos; J K Dibaise; T T Nostrant; N H Stollman; P K Anderson; S A Edmundowicz; D O Castell; M S Kim; J C Rabine; D S Utley
Journal:  Gastrointest Endosc       Date:  2001-04       Impact factor: 9.427

4.  The role of acid and duodenal gastroesophageal reflux in symptomatic GERD.

Authors:  G H Koek; J Tack; D Sifrim; T Lerut; J Janssens
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

5.  Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium.

Authors:  N A Tobey; J L Carson; R A Alkiek; R C Orlando
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

6.  Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings.

Authors:  D Sifrim; R Holloway; J Silny; Z Xin; J Tack; A Lerut; J Janssens
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

7.  The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.

Authors:  George Triadafilopoulos; John K DiBaise; Timothy T Nostrant; Neil H Stollman; Paul K Anderson; M Michael Wolfe; Richard I Rothstein; John M Wo; Douglas A Corley; Marco G Patti; Louis V Antignano; John S Goff; Steven A Edmundowicz; Donald O Castell; John C Rabine; Michael S Kim; David S Utley
Journal:  Gastrointest Endosc       Date:  2002-02       Impact factor: 9.427

Review 8.  A critical review of endoscopic therapy for gastroesophageal reflux disease.

Authors:  Walter J Hogan; Reza Shaker
Journal:  Am J Med       Date:  2003-08-18       Impact factor: 4.965

9.  Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux.

Authors:  C Calabrese; A Fabbri; M Bortolotti; G Cenacchi; A Areni; C Scialpi; M Miglioli; G Di Febo
Journal:  Aliment Pharmacol Ther       Date:  2003-09-01       Impact factor: 8.171

Review 10.  Gatekeeper Reflux Repair System: technique, pre-clinical, and clinical experience.

Authors:  Paul Fockens
Journal:  Gastrointest Endosc Clin N Am       Date:  2003-01
View more
  17 in total

1.  Determinants of perception of heartburn and regurgitation.

Authors:  A J Bredenoord; B L A M Weusten; W L Curvers; R Timmer; A J P M Smout
Journal:  Gut       Date:  2005-08-24       Impact factor: 23.059

2.  Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease.

Authors:  D Sifrim
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

3.  Gatekeeper reflux repair system; a mechanistic hypothesis.

Authors:  P J Kahrilas; T J Lee
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

Review 4.  Endoluminal and transluminal surgery: current status and future possibilities.

Authors:  A Malik; J D Mellinger; J W Hazey; B J Dunkin; B V MacFadyen
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

Review 5.  Endolumenal therapies for gastroesophageal reflux disease: are they dead?

Authors:  Jonathan P Pearl; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2007-01       Impact factor: 4.584

6.  Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease.

Authors:  Toshitaka Hoppo; Arul Immanuel; Matthew Schuchert; Zdenek Dubrava; Andrew Smith; Peter Nottle; David I Watson; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2010-09-28       Impact factor: 3.452

7.  Endoscopic fundoplication: real or fantasy?

Authors:  Alejandro Nieponice; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2011-06-10       Impact factor: 3.452

Review 8.  Recent advancement of therapeutic endoscopy in the esophageal benign diseases.

Authors:  Robert Bechara; Haruhiro Inoue
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

9.  Endoscopic therapy for GERD: is the evidence for efficacy any stronger?

Authors:  Pankaj J Pasricha; Binh V Pham
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

10.  Initial experience with new intraluminal devices for GERD, Barrett's esophagus, and obesity.

Authors:  Charles J Filipi; Rudolf J Stadlhuber
Journal:  J Gastrointest Surg       Date:  2009-09-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.